Tweet
We have been preparing libraries for Illumina GA and we have some problems with RNA-seq libraries. The issue that we are having is that we are seeing two peaks in bioanalyzer data (attached ppt). We are seeing this in all our RNA seq samples - no matter what organism used. We are using Illumina RNAseq kit. have anyone seen something like this? I would really appreciate any advice.
-
-
I've seen this with ChIP-Seq libraries. I think the double peak is due to library PCR dimers forming. This is similar to primer-dimers but forms from PCR products dimerizing.
You see this more often if you use high cycle numbers in your amplification. -
This happens in about a third of my RNA-Seq library preps. Try using the ultrapure T4 ligase from Enzymatics and titrating the amount of primers in the final step, going down by 0.1ul amounts from 1ul.Comment
-
two rounds DSN normalization
hello
has anyone tried to do two rounds of DSN normalization (specifically for RNA-seq)? If so, how did you do it and how did it go? Thanks.Comment
-
I have done just one round of DSN normalization using Illumina's DSN normalization kit. The protocol of which can be found at http://qb3.berkeley.edu/gsl/Protocol...OT_RELEASE.pdfOriginally posted by zorph View PostComment
-
We are also seeing double peaks in our RNA-seq library preps, even though all samples have been gel extracted at 350bp. Does anyone know how it is possible to still have 700 bp fragments after gel extraction and what we can do to remove the longer fragments? Thanks.Comment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment